EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?

Aileen G Rowan, Charles R M Bangham

Leukemia Research and Treatment · 2012

DOI: 10.1155/2012/391953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia Research and Treatment, 2012. Verfasst von Aileen G Rowan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Wright-Fleming Institute, Imperial College London, London W2 1PG, UK. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Wellcome Trust.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ATLL is an aggressive malignancy of T cells that affects about 5% of individuals infected with HTLV-1. The precise mechanism of oncogenesis is not known, but there is evidence that two regulatory viral proteins, Tax and HBZ, are involved. A high set point proviral load is associated with development of ATLL or a chronic inflammatory condition, HAM/TSP. Several lines of evidence, including HLA class 1 association studies and in vitro killing assays, indicate that cytotoxic T lymphocytes are instrumental in determining this proviral load set point. Prior studies have focused chiefly on the CTL response to the immunodominant Tax protein: efficient lysis of Tax-expressing cells inversely correlates with proviral load in nonmalignant infection. However, a recent study showed that strong binding of peptides from HBZ, but not Tax, to HLA class 1 molecules was associated with a low proviral load and a reduced risk of developing HAM/TSP, indicating an important role for HBZ-specific CTL in determining infection outcome. In comparison with nonmalignant infection, HTLV-1-specific CTLs in ATLL patients are reduced in frequency and functionally deficient. Here we discuss the nature of protective CTL responses in nonmalignant HTLV-1 infection and explore the potential of CTLs to protect against ATLL.

Autor:innen und Institutionen

  • Department of Immunology, Wright-Fleming Institute, Imperial College London, London W2 1PG, UK.

Förderung

  • Wellcome Trust

Zitieren

APA

Rowan, A. G., & Bangham, C. R. (2012). Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?. Leukemia Research and Treatment. https://doi.org/10.1155/2012/391953

Vancouver

Rowan AG, Bangham CR. Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?. Leukemia Research and Treatment. 2012. doi:10.1155/2012/391953

BibTeX
@article{Rowan2012,
  author = {Rowan, Aileen G and Bangham, Charles R M},
  title = {Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?},
  journal = {Leukemia Research and Treatment},
  year = {2012},
  doi = {10.1155/2012/391953}
}
Kostenlos starten →